Political Economy and Research Silos: A Response to the Recent Commentaries

Document Type : Correspondence

Authors

1 Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia

2 School of Politics and International Studies, University of Leeds, Leeds, UK

Keywords


The responses to our paper “‘Part of the Solution’: Food Corporation Strategies for Regulatory Capture and Legitimacy"1greatly expand on our case study of a shift in the strategy of powerful food companies and develop a myriad of new avenues for analysis. The strongest theme in the responses was the emphasis on how, practically, to counter the power and influence of commercial actors. A second theme considered how to go beyond a narrow focus on specific industry sectors and identify cross-cutting commonalities across commercial actors. A final thread challenged our assertion that there are dangers in working with industry actors and reflected on what trade-offs might be acceptable in the pursuit of public health. ...(Read more...)

  1. Lacy-Nichols J, Williams O. "Part of the solution": food corporation strategies for regulatory capture and legitimacy. Int J Health Policy Manag. 2021;10(12):845-856. doi:34172/ijhpm.2021.111
  2. Howard PH. Concentration and Power in the Food System: Who Controls What We Eat? Bloomsbury Publishing; 2021.
  3. Kloppenburg JR Jr. First the Seed: The Political Economy of Plant Biotechnology, 1492-2000. Cambridge: Cambridge University Press; 1988.
  4. Sell SK, Williams OD. Health under capitalism: a global political economy of structural pathogenesis. Rev Int Polit Econ. 2020;27(1):1-25. doi:1080/09692290.2019.1659842
  5. Sparke M, Williams OD. Neoliberal disease: COVID-19, co-pathogenesis and global health insecurities. Environ Plan A. 2022;54(1):15-32. doi:1177/0308518x211048905
  6. Freudenberg N. Responding to food industry initiatives to be "part of the solution": Comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2740-2743. doi:34172/ijhpm.2022.7241
  7. Crosbie E, Carriedo A. Applying a commercial determinants of health lens to understand, expose and counter industry co-option, appeasement and partnership comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2744-2747. doi:34172/ijhpm.2022.7371
  8. Global Data Barometer. First Edition Report – Global Data Barometer. 2022. https://globaldatabarometer.org/wp-content/uploads/2022/05/GDB-Report-English.pdf.
  9. Baum F, Anaf J. A world beyond transnational corporations: meeting human rather than corporate need comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2748-2751. doi:34172/ijhpm.2022.7540
  10. Lencucha R. Situating food industry influence: governance norms and economic order comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2736-2739. doi:34172/ijhpm.2022.7197
  11. Transnational Institute. Reclaiming Public Services: How Cities and Citizens Are Turning Back Privatisation. 2017. https://www.tni.org/files/publication-downloads/reclaiming_public_services.pdf. Accessed February12, 2022.
  12. Wiist WH. The foundations of corporate strategies comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2732-2735. doi:34172/ijhpm.2022.7174
  13. Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023. doi:1016/S0140-6736(23)00013-2
  14. Lacy-Nichols J, Nandi S, Mialon M, et al. Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations. Lancet. 2023. doi:1016/S0140-6736(23)00012-0
  15. Allen LN. Trust, but verify comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy.” Int J Health Policy Manag. 2022;11(11):2727-2731. doi:34172/ijhpm.2022.7008
  16. Baum FE, Sanders DM, Fisher M, et al. Assessing the health impact of transnational corporations: its importance and a framework. Global Health. 2016;12(1):27. doi:1186/s12992-016-0164-x
  17. Draft Revised Recommendation of the Council on Transparency and Integrity in Lobbying and Influence. 2022. https://www.oecd.org/gov/ethics/lobbying/OECD-draft-revised-Recommendation-of-the-Council-on-Transparency-and-Integrity-in-Lobbying-and-Influence.pdf. Accessed February 13, 2023.
  18. Crawford R. Healthism and the medicalization of everyday life. Int J Health Serv. 1980;10(3):365-388. doi:2190/3h2h-3xjn-3kay-g9ny
  19. Galbraith JK. American Capitalism: The Concept of Countervailing Power. Vol 619. Boston: Houghton Mifflin; 1952.
  • Receive Date: 19 February 2023
  • Revise Date: 28 February 2023
  • Accept Date: 01 March 2023
  • First Publish Date: 04 March 2023